ライフサイエンスコーパス: ED

1 ED length of stay (ED-LOS); ICU length of stay (ICU-LOS)

2 ED peptide supported recovery and regrowth of monoaminer

3 ED(DLP) (13.2 +/- 4.5 mSv) was higher compared to ED(NCI

4 ED(MC) was compared to ED(DLP) and ED(NCI).

5 ue to scabies (prevalence = 85.7 per 100 000 ED visits).

6 ediatric ED use (no visits versus at least 1 ED visit in the first 5 years of life) and ED utilisatio

7 erall, 3,104 (30.5%) children had at least 1 ED visit in the first 5 years of life, with the highest

8 le children aged 0-18 years presenting to 12 EDs in 8 European countries (Austria, Germany, Greece, L

9 Stepped-wedge cluster randomized trial in 15 EDs in France of 503 patients 75 years and older with a

10 tronic health record and billing data for 16 EDs in Indiana and 11 hospitals in the Dallas-Fort Worth

11 14.0% vs 21.9%, ARR 95%CI: -10.7% to -5.2%), ED utilization (51.7% vs 57.2%, ARR 95%CI: -9.1% to -1.9

12 Our patient population included 416 017 218 ED visits from 2013 to 2015, of which 356 267 were due t

13 006 to 2017, there were an estimated 350 379 ED visits in the US with a primary diagnosis of orbital

14 y three-dimensional electron diffraction (3D ED), which revealed that ABTPA uses out-of-plane anthrac

15 h three-dimensional electron diffraction (3D-ED) data has been used to solve structures of sub-microm

16 structure solution of COF materials from 3D-ED data of limited resolution, which may facilitate the

17 r structure determination of COF-300 from 3D-ED data.

18 e solution achieved from room-temperature 3D-ED data with a resolution as low as ca. 3.78 angstrom.

19 ds differed for WD and PLA2 ED vs PLC and 3G ED.

20 tty acids into gum bilayers after PLC and 3G ED.

21 20.1% vs 27.7%, ARR 95%CI: -10.7% to -4.6%), ED utilization (71.6% vs 77.1%, ARR 95%CI: -8.5% to -2.4

22 prescriptions ranged from 0.7 to 1.8 across EDs.

23 3%), and inconclusive in 22.5% (range across EDs: 0.4%-60.8%).

24 ptions, inappropriate in 12.5% (range across EDs: 0.6%-29.3%), and inconclusive in 22.5% (range acros

25 ncomplicated RTIs and in 45.1% (range across EDs: 11.1%-100%) of prescriptions in uncomplicated urina

26 h the local guideline in 22.3% (range across EDs: 11.8%-47.3%) of prescriptions in uncomplicated RTIs

27 ic prescription rate was 31.9% (range across EDs: 22.4%-41.6%), and among those prescriptions, the br

28 ic prescription rate was 52.1% (range across EDs: 33.0%-90.3%).

29 n in 20% of oral prescriptions (range across EDs: 4.4%-59.0%).

30 The total inflation-adjusted ED charges over the study period exceeded $2 billion, wi

31 s in annual incidence and inflation-adjusted ED charges.

32 vember 2013 to April 2014, we enrolled adult ED patients with fever or respiratory symptoms who met c

33 dize testing for high-risk patients in adult EDs during influenza seasons, potentially improving diag

34 vation of phosphorylated MARCKS levels after ED peptide treatment.

35 Although ED symptoms were not associated with an overall increase

36 Over-testing for PE in American EDs remains a major public health problem.

37 incidence and burden of scabies in American EDs.

38 timates regarding scabies visits to American EDs.

39 The relative frequency of GBS among ED patients was higher in COVID (0.15 per mille) than no

40 centrations were generally much higher among ED patients with syncope who had a 30-day SAE, this bloo

41 However, among ED users, children of migrant mothers attend the service

42 tients referred for ophthalmic care after an ED presentation were LTFU.

43 s were nearly 9 times more likely to have an ED referral when triaged by a clinician (OR 8.72, 95% CI

44 First, we tested an ED/PS cell in series with pertraction and achieved a max

45 Prior to an ED visit, there was a significant increase in depressed

46 wth (RG), early decline (ED), and RG with an ED (RGED)-have been observed, with RG and RGED associate

47 LTFU was significantly associated with an ED revisit within 4 months of an index visit, and the ED

48 have robust target engagement in rat with an ED(70) of 1.4 mg/kg.

49 pital admission (AOR = 1.60, p < 0.001); and ED visits (AOR = 1.58, p < 0.001).

50 eclined for hospitalization (49% vs 10%) and ED visits (49% vs 8%).

51 Participants of AD and ED with glaucoma were of similar age and glaucoma severi

52 Department (ED) visit for constipation, and ED visit for pain.

53 ED(MC) was compared to ED(DLP) and ED(NCI).

54 Rotavirus-associated hospitalization and ED visit rates were calculated annually with 2006-2007 d

55 ase burden of rotavirus hospitalizations and ED visits were examined from 2006 to 2016.

56 ased rates of influenza hospitalizations and ED visits.

57 1 ED visit in the first 5 years of life) and ED utilisation rates (number and frequency of ED visits)

58 e frequency of and risk factors for LTFU and ED revisits.

59 er compared to ED(NCI) (9.8 +/- 2.1 mSv) and ED(MC) (11.6 +/- 1.5 mSv).

60 associations between BB, SS, OP, and RO, and ED visits or hospitalizations for influenza, but not cul

61 ossibility of reducing LOS, triage time, and ED crowding in addition to improving the experience of p

62 Both WD and ED resulted in lamellar liquid-crystalline phases, howev

63 active hyperemic index <=1.35 was defined as ED.

64 All VOE subjects at ED presentation had significantly decreased complex-V ac

65 esentative of all febrile children attending EDs in that country.

66 representative sample of all hospital-based EDs in the US, was used to identify and describe ED visi

67 ts indicate that the performance gap between ED and MCDI is substantial for typical brackish water de

68 inconclusive, with marked variation between EDs.

69 This miR was downregulated in both ED groups (ie, ED and RGED).

70 identification at the point of treatment by ED services is necessary to inform the targeted deployme

71 tment electrodialysis/phase separation cell (ED/PS).

72 y syncytial virus was detected in community, ED (both 0.3 per 1000 child-years), and hospital (2.4 pe

73 g peripheral arterial tonometry, we compared ED in YLPHIV and age-matched youth without HIV.

74 nding hospitals had the lowest complication, ED visit, post-acute utilization, and readmission rates

75 ssociated with lower rates of complications, ED visits, post-acute utilization, and readmissions.

76 growth, reduced growth (RG), early decline (ED), and RG with an ED (RGED)-have been observed, with R

77 yet to arrive next injured patient decreases ED dwell times, complications, HLOS, and in-hospital mor

78 ater degumming (WD) and enzymatic degumming (ED) were studied at a range of phospholipid and water co

79 creases outpatient and emergency department (ED) access to cardiology care is associated with reduced

80 re discharged from the emergency department (ED) after a traumatic event(1).

81 ecimens (n = 200) from emergency department (ED) and intensive care unit (ICU) patients at a tertiary

82 ultures in a pediatric emergency department (ED) and sought to determine changes in recovery of oblig

83 ) for influenza in the emergency department (ED) could improve treatment and isolation strategies and

84 the largest all-payer emergency department (ED) database, between 2013 and 2016, we identified patie

85 Prolonged emergency department (ED) dwell time before admission to a critical care unit

86 s who presented to the emergency department (ED) of a multicenter urban health system from March 10 t

87 tract infection in the emergency department (ED) of Lausanne University Hospital.

88 ere recruited from the emergency department (ED) or inpatient settings at Vanderbilt Children's Hospi

89 r prescribing included emergency department (ED) or urgent care settings (versus regular office), oto

90 isions for those adult emergency department (ED) patients deemed appropriate for antiviral treatment

91 yls were measured from emergency department (ED) presentation vs discharge.

92 Rates of direct emergency department (ED) referral were compared between insurance types.

93 tudy from the National Emergency Department (ED) Sample was designed to identify patients presenting

94 e heart failure in the emergency department (ED) setting are based on only moderate levels of evidenc

95 nostic information for emergency department (ED) syncope.

96 g participants seeking emergency department (ED) treatment in the aftermath of a traumatic life exper

97 comes included refill, Emergency Department (ED) visit for constipation, and ED visit for pain.

98 media change prior to emergency department (ED) visits and inpatient hospital admissions in this cas

99 egarding the burden of emergency department (ED) visits due to scabies in the United States.

100 Changes in emergency department (ED) visits for dental problems were estimated by fitting

101 f hospitalizations and emergency department (ED) visits for influenza or culture-negative pneumonia f

102 ) hospitalizations and emergency department (ED) visits in 3 United States counties.

103 dmissions, procedures, emergency department (ED) visits, and outpatient clinic encounters before age

104 length of stay (LOS), emergency department (ED) visits, and readmissions.

105 ents presenting to the emergency department (ED) with acute dyspnea is challenging.

106 ents presenting to the emergency department (ED) with an acute asthma exacerbation and correlate thes

107 d who presented to the emergency department (ED) with primary nonrespiratory (gastrointestinal or neu

108 omy, 22% revisited the emergency department (ED) within 90 days, and 12.5% were readmitted.

109 sified into community, emergency department (ED), and hospital levels to estimate infection rates.

110 children visiting the emergency department (ED), contributing to antimicrobial resistance.

111 tion, in pre-hospital, Emergency Department (ED), or general hospital ward locations, who are in a hi

112 ted CAP in a pediatric emergency department (ED).

113 influenza cases in the emergency department (ED).

114 al presentation to the emergency department (ED); outcomes of interest included hospitalization, intu

115 reated at the emergency medicine department (ED) of the Government Medical College, Kozhikode (GMCK).

116 Total initial (emergency department [ED]) health care costs for persons with index firearm in

117 atients presenting to emergency departments (EDs) and potentially overwhelming health systems.

118 s Europe suggest that emergency departments (EDs) are used more, and differently, by migrants compare

119 ttended at 61 Spanish emergency departments (EDs) during the 2-month pandemic peak.

120 y embolism (PE) in US emergency departments (EDs), and no data have examined computed tomographic pul

121 D) loss in participants of European descent (ED) and African descent (AD) were compared.

122 in the US, was used to identify and describe ED visits with a primary diagnosis of orbital floor frac

123 e evidence on the impact of early discharge (ED) on healthy mothers and term newborns after vaginal d

124 s, using a 4 day cutoff for early discharge, ED) regression.

125 that cell permeable MARCKS effector domain (ED) peptides potently target all GBM molecular classes w

126 its functionally essential effector domain (ED) to polysialic acid.

127 fear behaviors with a median effective dose (ED(50)) of 4 mg/kg.

128 conventional calculation of effective dose (ED) for computed tomography (CT) is based on dose length

129 However, electrodialysis (ED), despite being a more mature electro-driven technolo

130 Large studies at European EDs covering diversity in antibiotic and broad-spectrum

131 we observed wide variation between European EDs in prescriptions of antibiotics and broad-spectrum a

132 ll secondary outcomes for the PVI arm: fewer ED visits and readmissions, and shorter initial and tota

133 rnst-Planck based models for continuous flow ED and constant-current membrane capacitive deionization

134 For ED, phospholipase C (PLC), phospholipase A2 (PLA2) and a

135 nces were up to -48% for ED(MC) and -44% for ED(NCI) compared to ED(DLP).

136 e individual differences were up to -48% for ED(MC) and -44% for ED(NCI) compared to ED(DLP).

137 xpression of miR-145-5p is a risk factor for ED of long-term lung function.

138 nd glaucomatous eyes for cpCD was higher for ED (0.95) compared with AD (0.68) patients (P < 0.001).

139 nt than structural uncertainty, at least for ED-2.2 in Upper Midwest forests and (b) simulating both

140 mprovements were seen in the POST period for ED-LOS, HLOS, complications, and in-hospital mortality.

141 Routine use of NT-proBNP for ED syncope prognostication is not recommended.

142 ED, offering a 1- to 3-week warning sign for ED influx of triple or quadruple the number of influenza

143 n ensemble machine learning model forecasted ED visits and inpatient admissions with out-of-sample cr

144 ARI severity in young children enrolled from ED and inpatient settings, but no differences in disease

145 ominal pain in patients referring to general EDs or GI clinics if a positive history of opium abuse e

146 VD than SVD, and although a decline of LoS > ED and mean LoS over time was observed for both VDM, the

147 and the pooled regional proportion of LoS > ED was 64.4% for SVD and 32.0% for IVD.

148 easing trend over time in mean LoS and LoS > ED was observed for both PCS and UCS.

149 Any prolonged LoS post VD (LoS > ED) should be reviewed and audited if need be.

150 ility to the broad, clinically heterogeneous ED population under conditions of routine medical care.

151 ceive touch in the presence of a light, High ED participants were differentially affected by self-foc

152 ED symptoms, versus 26 women reporting high ED symptoms, undertook a modified version of the Somatic

153 For the High ED group, physiological arousal, and tactile sensitivity

154 We suggest that in those with High ED symptoms, attention to the bodily self may exacerbate

155 patients seen in the Laghman Hakim Hospital ED and GI clinic who were lead-intoxicated, with or with

156 miR was downregulated in both ED groups (ie, ED and RGED).

157 patients with nonshockable rhythm (change in ED survival rate trend, 1.3% [95% CI, 0.89%-1.74%]; P<0.

158 nders, significantly lower cpCD was found in ED eyes compared with AD eyes in mild glaucoma (mean, 42

159 iagnostic accuracy for detecting glaucoma in ED patients, their diagnostic accuracy was only modest i

160 s associated with only slight improvement in ED survival and survival-to-discharge trends among US OH

161 ia as a screening tool; however, its role in ED screening and identification has yet to be fully eluc

162 y density loss was greater in all sectors in ED compared with AD participants, a similar sectoral pat

163 gen receptor inhibitor to the extent seen in ED peptide-treated female neurons.

164 ificity in AD participants was lower than in ED participants for cpCD (0.32 [95% CI, 0.11-0.64] vs. 0

165 ed whether alterations in body perception in EDs extend to the integration of exteroceptive visual an

166 f variability in antibiotic prescriptions in EDs and its relation with viral or bacterial disease is

167 ification in COVID-19 patients presenting in EDs.

168 limitation of our study is that the included EDs are not representative of all febrile children atten

169 pleted follow-up within 2 months of an index ED visit.

170 9%) of which were identified after the index ED disposition.

171 ether the SAE was identified after the index ED visit.

172 om BiB mothers, and Bradford Royal Infirmary ED episode data for their children.

173 uenza hospitalizations, N = 57 522 influenza ED visits, N = 274 226 culture-negative pneumonia hospit

174 These results demonstrate that in a large ED sepsis database the earliest measurement of end organ

175 Leukocidin ED (LukED) is a pore-forming toxin produced by Staphyloc

176 y tau-RNA/heparin complex coacervation (LLPS-ED).

177 y leads to canonical tau fibrils, while LLPS-ED is reversible, remains hydrated and does not promote

178 -Fort Worth area from 2016 to 2019 to locate ED patients who had any of the following: D-dimer, CTPA,

179 Twenty-seven women reporting low ED symptoms, versus 26 women reporting high ED symptoms,

180 For the Low ED group, sensitivity (d') and physiological arousal wer

181 uantitative molecular diagnostics in the MAL-ED cohort.

182 These results indicate that MARCKS ED peptide therapeutics may overcome traditional GBM res

183 (mean [SD] age, 65.8 [17.2] years; 62% men), ED survival rate (23%) and survival-to-discharge rate (1

184 n vivo activity in P. berghei-infected mice (ED(50) ~ 0.5 mg/kg) when administered by the ip route an

185 ts on two independent prospective cohorts of ED patients, future research should extend the generaliz

186 productivity), with the energy efficiency of ED often exceeding 30% and being nearly an order of magn

187 D utilisation rates (number and frequency of ED visits) for children who have accessed the ED.

188 Our findings show that patterns of ED utilisation differ by mother's region of origin and t

189 MCDI is unable to attain the performance of ED, even with ideal and optimized operation.

190 YLPHIV had higher rates of ED than youth without HIV (50% vs 34%; P = .01); this re

191 Increased rates of ED visits for influenza were associated with interquarti

192 es, YLPHIV appear to be at increased risk of ED compared with age-matched youth without HIV.

193 Risk of ED visit for constipation (n = 61, 1%) was increased wit

194 There was similar or increased risk of ED visit for pain (n = 319, 5%) with opioid prescription

195 ioid prescription duration increased risk of ED visits for constipation, but not for pain or refill.

196 outcome studied was the change in trends of ED survival and survival-to-discharge rates before and a

197 underlying health status and the urgency of ED attendance, as well as the analysis being limited by

198 policy was performed to assess the impact on ED dwell time, ICU and hospital lengths of stay, complic

199 lture-negative pneumonia hospitalizations or ED visits.

200 gs (versus regular office), otolaryngologist/ED doctors (versus primary care), fewer comorbidities, a

201 Second, we evaluated our ED/PS as a stand-alone unit when integrated with the ana

202 o examine the association between paediatric ED utilisation in the first 5 years of life and maternal

203 is no higher likelihood of first paediatric ED attendance in the first 5 years of life for children

204 Main outcomes were likelihood of paediatric ED use (no visits versus at least 1 ED visit in the firs

205 nteraction Therapy-Emotion Development (PCIT-ED) or waitlist.

206 .98, p = .02, partial eta(2) = .07) for PCIT-ED, but a greater change in RewP was not significantly a

207 from 118 children randomly assigned to PCIT-ED (n = 60) or waitlist (n = 58) at baseline and late po

208 ) data from 99 children (44 assigned to PCIT-ED vs. 55 assigned to waitlist) at baseline.

209 ressive disorder in children undergoing PCIT-ED (B = 0.14; SE = 0.07; odds ratio = 1.15; p = .03).

210 Children undergoing PCIT-ED showed a greater reduction in anhedonia (F(1,103) = 1

211 This was a cohort study in a pediatric ED (August 2015 to July 2018) that began in February 201

212 amphiphilic lipids differed for WD and PLA2 ED vs PLC and 3G ED.

213 , and N = 113 997 culture-negative pneumonia ED visits included in our analyses.

214 e percentage of LoS longer than our proposed ED benchmarks following VD: 2 days after spontaneous vag

215 In addition, dental-related ED visits would be expected to grow by 4.0%.

216 Eye-related ED patients who underwent CT or MRI.

217 Advanced imaging for eye-related ED visits has escalated at a higher rate than ED visits

218 e rose 94%, from 121.7 per 1,000 eye-related ED visits in 2007 to 236.0 per 1,000 eye-related ED visi

219 isits in 2007 to 236.0 per 1,000 eye-related ED visits in 2015.

220 An estimated 7 million eye-related ED visits occurred between 2007 and 2015.

221 Adjusted for annual eye-related ED visits, the rate of imaging use rose 94%, from 121.7

222 Each patient's ED chest radiograph was divided into six zones and exami

223 Scabies ED patients that were male, older, insured by Medicare,

224 The average cost of care for a scabies ED visit was $750.91 (+/-17.41).

225 The average annual expenditure for scabies ED visits was $67 125 780.36.

226 Outcomes included adjusted odds for scabies ED visits, adjusted odds for inpatient admission due to

227 sentative estimates of the burden of scabies ED visits on the American healthcare system.

228 variation in cost and prevalence of scabies ED visits.

229 By ensuring equivalently sized ED and MCDI systems-in addition to using the same feed s

230 ED length of stay (ED-LOS); ICU length of stay (ICU-LOS); hospital length o

231 D visits has escalated at a higher rate than ED visits for eye complaints.

232 We find that ED consumes less energy (has higher energy efficiency) t

233 D visits) for children who have accessed the ED.

234 .001), scheduled follow-up >5 days after the ED visit (P < .001), additional follow-up appointments (

235 t within 4 months of an index visit, and the ED revisit rate was significantly higher for patients LT

236 A 25-mer peptide comprising the ED of MARCKS stimulates neuritogenesis of primary hippoc

237 06 per member) for those discharged from the ED and 2138% (from $4118 to $92 151 per member) for thos

238 sed by 187% for patients discharged from the ED and 608% for those who were hospitalized.

239 irearm injuries who were discharged from the ED were $8 158 786 ($5686 per member).

240 2017 and January 2018, patients seen in the ED and GI clinic of Loghman Hakim Hospital with unexplai

241 ts aged >=18 years who were evaluated in the ED at a Mayo Clinic site with dyspnea.

242 eline-based comprehensive care bundle in the ED compared with usual care did not result in a statisti

243 edical records of 2,206 patients seen in the ED for an eye-related issue who were subsequently schedu

244 th a diagnosis of acute heart failure in the ED from December 2018 to September 2019 and followed up

245 1 and IL-6 concentrations in COVID-19 in the ED have good predictive accuracy for intubation/mortalit

246 Isolation was more often initiated in the ED in the hospital using POCT (91% versus 80%, p=0.025).

247 dy of PCR-confirmed COVID-19 patients in the ED of a Swiss hospital.

248 The study included 12 cases treated in the ED of GMCK.

249 POCT implementation in the ED resulted in improved targeted isolation and shorter L

250 or inpatient admission due to scabies in the ED scabies population, predictors for cost of care, and

251 atients with ACP with significant CAD in the ED setting and reduce unnecessary downstream testing.(C)

252 specimen (2187 hospitalized and 4767 in the ED).

253 an influx in influenza-positive cases in the ED, offering a 1- to 3-week warning sign for ED influx o

254 st CT, and underwent COVID-19 testing in the ED.

255 ss test which can be quickly obtained in the ED.

256 nts who had refractory cardiac arrest in the ED.

257 In female but not male neurons, the ED peptide enhanced neurite outgrowth that could be supp

258 In male neurons, the ED peptide enhanced neuritogenesis in the presence of an

259 dard 12-lead ECG acquired on the date of the ED visit and an echocardiogram performed within 30 days

260 ho were LTFU were more likely to revisit the ED for the same ophthalmic condition.

261 er 6 times more likely to be referred to the ED (OR 6.46, 95% CI 4.63-9.01).

262 than private patients to be referred to the ED [odds ratio (OR) 1.32, 95% confidence interval (CI) 1

263 Among 1 282 520 patients presenting to the ED after OHCA (mean [SD] age, 65.8 [17.2] years; 62% men

264 t biomarkers at clinical presentation to the ED for adverse outcome.

265 95) and IL-6 measured at presentation to the ED had the best accuracy for 30-day oxygen requirement (

266 ages of 21 and 50 years who presented to the ED of an urban multicenter health system from March 10 t

267 tiles and were most likely to present to the ED on weekdays in the fall, controlling for all other fa

268 igned to identify patients presenting to the ED primarily after an OHCA in the United States between

269 e more likely to be referred directly to the ED versus privately insured patients.

270 9.7 [standard deviation]) presenting to the ED with ACP.

271 Sixteen adults presenting to the ED with acute asthma exacerbations were recruited after

272 LVSD in selected patients presenting to the ED with dyspnea when analyzed with artificial intelligen

273 quired within 24hours of presentation to the ED) between patient groups based on their outcome at 7 d

274 ed an apparent emergent surgical case to the ED, potentially delaying care.

275 nificantly more likely to be referred to the ED; however, the disparity between private and Medicaid

276 rs were found to be less likely to visit the ED (odds ratio 0.88 [95% CI 0.80 to 0.97], p = 0.012).

277 The proportion of children who visited the ED at least once was lower for children of migrant mothe

278 However, among children who visited the ED, the utilisation rate was significantly higher for ch

279 Patients visiting the ED for scabies were most likely to be male children from

280 3 years of age hospitalized or visiting the ED with AGE were enrolled from January 2006 through June

281 howed that miR-145-5p is associated with the ED patterns of lung function growth leading to COPD in c

282 These EDs were based in university hospitals (n = 9) or large

283 ED(MC) was compared to ED(DLP) and ED(NCI).

284 for ED(MC) and -44% for ED(NCI) compared to ED(DLP).

285 P) (13.2 +/- 4.5 mSv) was higher compared to ED(NCI) (9.8 +/- 2.1 mSv) and ED(MC) (11.6 +/- 1.5 mSv).

286 to children with RSV infection presenting to ED or hospitalized were identified.

287 of children with RSV infection presenting to ED were diagnosed as other infection, other respiratory,

288 Sex-specific differences in response to ED peptide application also occurred in cultured neurons

289 lems were estimated by fitting trendlines to ED visit patterns by payer type.

290 focus on n = 666 participants presenting to EDs following a motor vehicle collision (MVC) and examin

291 hat accepted both insurance types, direct-to-ED referral rates for private and Medicaid patients were

292 lement the follow up of puerperae undergoing ED after VD.

293 redict the development of PTSD symptoms upon ED admission after trauma(5).

294 ospective cohort study was performed at 4 US EDs.

295 cally young and of childbearing age, utilise EDs for their children.

296 nd reinterventions), healthcare utilization (ED visits, rehospitalizations, and expenditures), and he

297 ic prescription in febrile children visiting EDs in Europe.

298 The primary outcomes were ED encounter volume-adjusted CTPA rate, PE yield rate wi

299 This motivated us to investigate whether ED peptide has similar effects in spinal cord injury.

300 sk, 0.90; P = .186) were not associated with ED after adjustment.